Gerald Fink, Ph.D. to Join GlycoFi Scientific Advisory Board.LEBANON, N.H. -- GlycoFi announced today that Gerald Fink, Ph.D. of the Whitehead Institute Founded in 1982, the Whitehead Institute for Biomedical Research is a non-profit research and teaching institution located in Cambridge, Massachusetts. The Whitehead Institute was founded as a fiscally independent entity from Massachusetts Institute of Technology, and its members and MIT MIT - Massachusetts Institute of Technology , has joined GlycoFi's scientific advisory board. Dr. Fink is well known for his seminal contributions to the area of yeast biology, and has developed baker's yeast as a model for studying the fundamental biology of all organisms. "We are very excited to welcome Dr. Fink to GlycoFi's scientific advisory board. As a pioneer in the area of yeast biology we look forward to Dr. Fink's input and leadership on the board," said Tillman Gerngross, Ph.D., GlycoFi's chief scientific officer. Gerald Fink is a founding member of the Whitehead Institute and American Cancer Society American Cancer Society, n.pr established in 1913, this national volunteer-based health organization is committed to the elimination of cancer through prevention and treatment and to diminishing cancer suffering through advocacy, scholarship, research, Professor of Genetics at MIT. He was director of the Whitehead from 1990 to 2001. Dr. Fink received his Ph.D. degree in genetics from Yale University Yale University, at New Haven, Conn.; coeducational. Chartered as a collegiate school for men in 1701 largely as a result of the efforts of James Pierpont, it opened at Killingworth (now Clinton) in 1702, moved (1707) to Saybrook (now Old Saybrook), and in 1716 was and served for 15 years on the faculty of Cornell University Cornell University, mainly at Ithaca, N.Y.; with land-grant, state, and private support; coeducational; chartered 1865, opened 1868. It was named for Ezra Cornell, who donated $500,000 and a tract of land. With the help of state senator Andrew D. . A past president of the Genetics Society of America The Genetics Society of America is a non-exclusive association of genetics researchers and educators, and the publisher of the peer-reviewed journal Genetics. The Genetics Society of America was established in 1931. , he is a member of the National Academy of Sciences, a fellow of the American Academy of Arts and Sciences, and a member of the Institute of Medicine. "I have followed with great interest the progress GlycoFi has made in engineering Pichia pastoris for use in humanizing and producing proteins of pharmaceutical importance. This was a tour de force in genetic engineering with the potential to make significant contributions to the drug discovery process," said Dr. Fink. About GlycoFi GlycoFi is a private, venture-backed, biotechnology company whose investors include Polaris Venture Partners, SV Life Sciences, Boston Millennia Partners, and Fletcher Spaght Ventures. GlycoFi leverages its pioneering protein optimization technology to develop, produce and commercialize Next Generation Biotherapeutics(TM), alone and in partnership with other leading biopharmaceutical companies. For additional information please visit www.glycofi.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion